Hematopoietic Progenitor Cell Transplant
Hematopoietic (blood-forming) progenitor cells (HPC), stem cells, bone marrow cells, and peripheral blood stem cells are all names for the cells found in the bone marrow and are known as the “parent” cells from which all other blood cells develop. The three main types of bloods cells are the red blood cell, white blood cells and platelets.
A special treatment, progenitor cell transplant, consists of high doses of chemotherapy, with or without radiation therapy, and progenitor cell infusion. The high dose treatment is such that the bone marrow is severely affected.
Hematopoietic progenitor cells are collected from the bone marrow or blood of the donor and given to the patient who received high dose therapy. The cells help their bone marrow and blood recover from the high dose therapy.
Throughout the remainder of this information the procedure will be referred to as HPCT (hematopoietic progenitor cell transplant).
Progenitor cell transplant may be offered to people who have certain cancers or non-cancerous disorders that may be cured, or where the progression of the disease may be delayed.